Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mert Oztas

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Rheumatology International|February 27, 2017
Atorvastatin-induced dermatomyositisMert Oztas, Serdal Ugurlu, Ovgu Aydin
Best Practice & Research. Clinical Rheumatology|October 2, 2025
Contemporary approaches to the management of rheumatoid arthritis: precision and progressTania Gudu, Mert Oztas, Elena Nikiphorou
Modern Rheumatology Case Reports|September 22, 2021
Haemophagocytic lymphohistiocytosis in a patient with familial Mediterranean fever and miliary tuberculosis: a case reportEmir Cerme, Mert Oztas, Ilker Inanc Balkan, et al.
International Journal of Rheumatic Diseases|June 26, 2023
Rituximab in the management of retroperitoneal fibrosis: A single tertiary rheumatology care center experienceMert Oztas, Izzet Altun, Ali Yagiz Ayla, et al.
Rheumatology International|March 29, 2021
Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based surveyBerna Yurttas, Burc Cagri Poyraz, Necdet Sut, et al.
Rheumatology International|June 10, 2021
Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderlyEmire Seyahi, Guldaran Bakhdiyarli, Mert Oztas, et al.
Rheumatology International|November 26, 2021
The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet's syndromeGuzin Ozcifci, Tahacan Aydin, Zeynep Atli, et al.
Journal of Medical Virology|March 22, 2022
Frequency and severity of COVID-19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquineMert Oztas, Murat Bektas, Ilker Karacan, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Rheumatology International|February 27, 2017
Atorvastatin-induced dermatomyositisMert Oztas, Serdal Ugurlu, Ovgu Aydin
Best Practice & Research. Clinical Rheumatology|October 2, 2025
Contemporary approaches to the management of rheumatoid arthritis: precision and progressTania Gudu, Mert Oztas, Elena Nikiphorou
Modern Rheumatology Case Reports|September 22, 2021
Haemophagocytic lymphohistiocytosis in a patient with familial Mediterranean fever and miliary tuberculosis: a case reportEmir Cerme, Mert Oztas, Ilker Inanc Balkan, et al.
International Journal of Rheumatic Diseases|June 26, 2023
Rituximab in the management of retroperitoneal fibrosis: A single tertiary rheumatology care center experienceMert Oztas, Izzet Altun, Ali Yagiz Ayla, et al.
Rheumatology International|March 29, 2021
Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based surveyBerna Yurttas, Burc Cagri Poyraz, Necdet Sut, et al.
Rheumatology International|June 10, 2021
Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderlyEmire Seyahi, Guldaran Bakhdiyarli, Mert Oztas, et al.
Rheumatology International|November 26, 2021
The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet's syndromeGuzin Ozcifci, Tahacan Aydin, Zeynep Atli, et al.
Journal of Medical Virology|March 22, 2022
Frequency and severity of COVID-19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquineMert Oztas, Murat Bektas, Ilker Karacan, et al.
Pageof 1